###begin article-title 0
Common Activation of Canonical Wnt Signaling in Pancreatic Adenocarcinoma
###end article-title 0
###begin p 1
Conceived and designed the experiments: MH MP AB SH RS. Performed the experiments: MP PH DC PG AB DS AD JK. Analyzed the data: MH MP AB DS JK. Contributed reagents/materials/analysis tools: AR SH RS TD AD. Wrote the paper: MH MP AB SH RS.
###end p 1
###begin p 2
###xml 185 190 <span type="species:ncbi:9606">human</span>
###xml 582 587 <span type="species:ncbi:9606">human</span>
###xml 648 653 <span type="species:ncbi:10090">mouse</span>
Pancreatic ductal adenocarcinoma (PDA) is an extremely aggressive malignancy, which carries a dismal prognosis. Activating mutations of the Kras gene are common to the vast majority of human PDA. In addition, recent studies have demonstrated that embryonic signaling pathway such as Hedgehog and Notch are inappropriately upregulated in this disease. The role of another embryonic signaling pathway, namely the canonical Wnt cascade, is still controversial. Here, we use gene array analysis as a platform to demonstrate general activation of the canonical arm of the Wnt pathway in human PDA. Furthermore, we provide evidence for Wnt activation in mouse models of pancreatic cancer. Our results also indicate that Wnt signaling might be activated downstream of Hedgehog signaling, which is an early event in PDA evolution. Wnt inhibition blocked proliferation and induced apoptosis of cultured adenocarcinoma cells, thereby providing evidence to support the development of novel therapeutical strategies for Wnt inhibition in pancreatic adenocarcinoma.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 235 238 235 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Hezel1">[1]</xref>
###xml 559 562 559 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Hruban1">[2]</xref>
###xml 742 745 742 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Biankin1">[3]</xref>
###xml 747 750 747 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Biankin2">[4]</xref>
###xml 870 873 870 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Miyamoto1">[5]</xref>
###xml 887 890 887 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Berman1">[6]</xref>
###xml 892 895 892 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Thayer1">[7]</xref>
###xml 190 198 <span type="species:ncbi:9606">patients</span>
Pancreatic ductal adenocarcinoma (PDA) is the fourth leading cause of cancer death in Western societies. The disease usually presents at an advanced stage, and as a result only 10 to 20% of patients are suitable for surgical resection [1]. Presently, non-operative therapies are widely ineffective, contributing to an overall 5 year survival-rate of less than 5%. There is now compelling histopathological and molecular evidence to support the evolution of PDA through a series of non-invasive duct lesions called pancreatic intraepithelial neoplasia (PanIN) [2]. Progression of PanIN lesion is associated with molecular aberrations that increase in frequency and correlate with advancing cellular atypia from early stages to invasive cancer [3], [4]. Recent studies have identified deregulation of pathways important in vertebrate pancreas development, including Notch [5] and Hedgehog [6], [7], in the development and progression of PDA.
###end p 4
###begin p 5
###xml 309 312 309 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-PascadiMagliano1">[8]</xref>
###xml 389 392 389 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Hebrok1">[9]</xref>
###xml 393 397 393 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Papadopoulou1">[13]</xref>
###xml 588 592 588 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Apelqvist1">[14]</xref>
###xml 594 598 594 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Kawahira1">[15]</xref>
###xml 712 716 712 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Heiser1">[10]</xref>
###xml 718 722 718 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Heller1">[16]</xref>
###xml 846 850 846 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Heiser1">[10]</xref>
###xml 958 962 958 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Heiser1">[10]</xref>
###xml 1039 1043 1039 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Nusse1">[17]</xref>
Interactions between embryonic signaling pathways ensure proper organ formation during development. Increasing evidence suggests that these pathways remain active in a subset of cells within adult organs and that deregulation of their activity contributes to the development and progression of certain tumors [8]. Hedgehog and Wnt signaling are involved in the development of the pancreas [9]-[13]. Both pathways appear to be regulated in a very tight manner during embryogenesis. Inappropriate activation of Hedgehog signaling during pancreas formation results in agenesis of this organ [14], [15]. A similar result is observed when Wnt signaling is activated at high levels during early pancreatic development [10], [16]. In contrast, activation of Wnt signaling predominately in acinar cells results in a significant increase in pancreas mass [10]. Ectopic activation of Wnt signaling at early stages of pancreas organogenesis increases Hedgehog activity [10]. While Hedgehog signaling is known to regulate Wnt activity in other organs [17], such regulation in developing pancreatic tissue has not yet been reported.
###end p 5
###begin p 6
###xml 164 168 164 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Gregorieff1">[18]</xref>
###xml 795 799 792 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Gregorieff1">[18]</xref>
###xml 801 805 798 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Lustig1">[19]</xref>
A large body of evidence supports the notion that uncontrolled activation of the canonical Wnt pathway induces tumor formation in the distal gastrointestinal tract [18]. Canonical Wnt signaling is activated when soluble Wnt ligands form a complex with one of several FRIZZLED receptors and LRP5/LRP6 co-receptors. This interaction triggers a cascade of events that results in the inhibition of ss-CATENIN phosphorylation. Non-phosphorylated ss-CATENIN translocates from the cytoplasm to the nucleus where it binds to the TCF-LEF family of transcription factors to activate the transcription of Wnt target genes. Upregulation of Wnt signaling, mediated by specific mutations in the APC or ss-CATENIN genes, is thought to play a critical role in the development of several gastrointestinal tumors [18], [19].
###end p 6
###begin p 7
###xml 178 182 178 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Bafico1">[20]</xref>
###xml 306 310 305 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Abraham1">[21]</xref>
###xml 432 436 430 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Murtaugh1">[11]</xref>
###xml 500 504 498 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-AlAynati1">[23]</xref>
###xml 506 510 504 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Lowy1">[24]</xref>
###xml 666 670 664 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Nawroth1">[25]</xref>
###xml 900 904 897 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Lowy1">[24]</xref>
Sustained tumor growth due to deregulation of Wnt signaling independent of mutations that increase pathway activity has been demonstrated in studies on breast and ovarian cancer [20]. Similarly, mutations in either APC or ss-CATENIN that are commonly found in other gastrointestinal cancer are rare in PDA [21]. However, aberrant cytoplasmic and nuclear expression of ss-CATENIN, both indicative of canonical Wnt signaling activity [11], , are present in a substantial group of PDA and PanIN samples [23], [24]. Moreover, heparan sulfate proteoglycans, known to regulate Wnt activity, are expressed in pancreatic adenocarcinoma and positively regulate cancer growth [25]. These data suggest that Wnt signaling may play a role in PDA despite the absence of signature mutations in APC or ss-CATENIN. Nevertheless, activation of the Wnt signaling pathway in pancreatic cancer has remained controversial [24] and functional studies addressing a potential contribution of Wnt signaling to PDA development and progression are currently missing.
###end p 7
###begin p 8
###xml 86 94 <span type="species:ncbi:9606">patients</span>
###xml 321 326 <span type="species:ncbi:10090">mouse</span>
###xml 704 719 <span type="species:ncbi:10090">transgenic mice</span>
Here we identify aberrant expression of Wnt signaling components in a large cohort of patients with PDA. Whilst only 13% of PDA demonstrate nuclear localization of ss-CATENIN, 65% demonstrate either loss of membranous expression and/or increased cytoplasmic expression. Similar results were obtained from the analysis of mouse models of pancreatic cancer. Assessment of PDA cell lines revealed activation of Wnt signaling and pathway inhibition showed that cancer cell survival and proliferation depends in part on Wnt activity. Increased levels of Hedgehog signaling constitute one of the earliest changes in PanIN lesions. Our results show that Hedgehog signaling activates ss-CATENIN/Wnt signaling in transgenic mice and untransformed pancreatic duct cells, suggesting that Hedgehog may play a role in upregulating Wnt activity in PDA.
###end p 8
###begin title 9
Results and Discussion
###end title 9
###begin p 10
###xml 132 136 132 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Heiser1">[10]</xref>
###xml 137 141 137 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Papadopoulou1">[13]</xref>
###xml 143 147 143 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Wells1">[26]</xref>
###xml 149 153 149 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Rulifson1">[27]</xref>
###xml 609 613 608 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-AlAynati1">[23]</xref>
###xml 615 619 614 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Lowy1">[24]</xref>
###xml 621 625 620 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Zeng1">[28]</xref>
###xml 851 855 846 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Murtaugh1">[11]</xref>
###xml 857 861 852 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Anderson1">[22]</xref>
###xml 1002 1011 994 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001155.s001">Figure S1</xref>
###xml 883 888 <span type="species:ncbi:9606">human</span>
A number of recent reports have characterized the role of Wnt signaling during pancreas development and function of the adult organ [10]-[13], [26], [27]. In contrast, the exact role canonical Wnt signaling plays in the formation and progression of PDA remains unclear. While robust activation of the pathway due to signature mutations in components of the Wnt cascade commonly observed in other gastrointestinal cancers have not been found in PDA, immunohistochemical analysis against ss-CATENIN, the key mediator of this pathway, suggests a contribution of Wnt signaling during PanIN progression and in PDA [23], [24], [28]. In normal adult pancreatic tissue beta-CATENIN is exclusively localized to the cell membrane and both cytoplasmic and nuclear localization of ss-CATENIN is commonly regarded as an indicator of active canonical Wnt signaling [11], [22]. Our analysis of 136 human PDA samples revealed nuclear beta-CATENIN expression in 17 (13%) and cytoplasmic expression in 89 (65%) samples (Figure S1). Thus, abnormal localization of beta-CATENIN, either nuclear or cytoplasmic, was detected in the majority of the tumor samples.
###end p 10
###begin p 11
###xml 388 396 388 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001155.s005">Table S1</xref>
###xml 342 350 <span type="species:ncbi:9606">patients</span>
To obtain more quantitative information about the level of Wnt signaling, we performed expression profiling of Wnt pathway components in PDA with genechip microarray. This analysis demonstrated aberrant expression of numerous components of the Wnt pathway in 12 PDA samples when compared to control tissue (6 normal specimens from the cancer patients and 12 samples of healthy pancreas) (Table S1). Expression of members of the FRIZZLED receptor family (FRIZZLED 2, 7 and 9), their ligands (WNT 2, 3, 4, 5A, 5B, 6, 8B and 11), and putative inhibitors of Wnt signalling (SECRETED FRIZZLED-RELATED PROTEIN 3 and 4 and DICKKOPF genes 1, 2 and 3) was increased in PDA compared to normal pancreas. Central pathway inhibitors such as ICAT were downregulated. In addition, expression of transcriptional target genes of ss-CATENIN, including CYCLIN D1, FIBRONECTIN, RETINOIC ACID RECEPTOR gamma, CYCLO-OXYGENASE 2, uPAR and MMP-7, were upregulated. Thus, the overall pattern, particularly the upregulation of direct transcriptional targets of Wnt signaling, suggests increased pathway activity. However, it should be noted that the overall increases in Wnt signaling targets appear smaller than those observed in other tumors, including colon cancer. This might be due to the fact that high level Wnt signaling requires mutations in pathway components, including ss-CATENIN and APC, that are not commonly observed in PDA. This raised the question of whether Wnt signaling is controlled by other signaling pathways known to be deregulated in PanIN and PDA.
###end p 11
###begin title 12
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
Increased Wnt signaling in a mouse model of PDA
###end title 12
###begin p 13
###xml 76 79 76 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Hezel1">[1]</xref>
###xml 109 113 109 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras</italic>
###xml 271 275 271 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Klimstra1">[29]</xref>
###xml 277 281 277 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Rozenblum1">[30]</xref>
###xml 341 345 341 345 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 329 345 329 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx-Cre;Kras<sup>G12D</sup></italic>
###xml 403 407 403 407 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 399 407 399 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 507 511 507 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Hingorani1">[31]</xref>
###xml 663 667 663 667 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 651 667 651 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx-Cre;Kras<sup>G12D</sup></italic>
###xml 684 688 684 688 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 692 695 692 695 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f/+</sup>
###xml 672 695 672 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx-Cre;Kras<sup>G12D</sup>;p53<sup>f/+</sup></italic>
###xml 785 789 785 789 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 773 789 773 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx-Cre;Kras<sup>G12D</sup></italic>
###xml 806 810 806 810 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 814 817 814 817 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f/+</sup>
###xml 794 817 794 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx-Cre;Kras<sup>G12D</sup>;p53<sup>f/+</sup></italic>
###xml 941 950 940 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001155-g001">Fig. 1A&#8211;D</xref>
###xml 955 963 954 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001155.s005">Table S1</xref>
###xml 1034 1039 1033 1038 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">axin2</italic>
###xml 1066 1070 1065 1069 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 1054 1070 1053 1069 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx-Cre;Kras<sup>G12D</sup></italic>
###xml 1106 1113 1105 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001155.s002">Fig. S2</xref>
###xml 1251 1255 1247 1251 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 1239 1262 1235 1258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx-Cre;Kras<sup>G12D</sup>;TOPGal</italic>
###xml 1382 1388 1378 1384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TOPGal</italic>
###xml 1501 1505 1497 1501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-DasGupta1">[32]</xref>
###xml 1590 1596 1585 1591 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TOPGal</italic>
###xml 1601 1615 1596 1610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx-Cre;TOPGal</italic>
###xml 1657 1664 1652 1659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001155-g001">Fig. 1E</xref>
###xml 1793 1797 1787 1791 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 1781 1804 1775 1798 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx-Cre;Kras<sup>G12D</sup>;TOPGal</italic>
###xml 1811 1818 1805 1812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001155-g001">Fig. 1F</xref>
###xml 66 71 <span type="species:ncbi:9606">human</span>
###xml 346 361 <span type="species:ncbi:10090">transgenic mice</span>
###xml 497 502 <span type="species:ncbi:9606">human</span>
###xml 696 700 <span type="species:ncbi:10090">mice</span>
###xml 744 749 <span type="species:ncbi:9606">human</span>
###xml 818 822 <span type="species:ncbi:10090">mice</span>
###xml 1263 1267 <span type="species:ncbi:10090">mice</span>
###xml 1389 1393 <span type="species:ncbi:10090">mice</span>
###xml 1573 1577 <span type="species:ncbi:10090">mice</span>
###xml 1805 1809 <span type="species:ncbi:10090">mice</span>
###xml 1935 1939 <span type="species:ncbi:10090">mice</span>
###xml 2015 2020 <span type="species:ncbi:9606">human</span>
###xml 2033 2038 <span type="species:ncbi:10090">mouse</span>
Deregulation of Kras activity is observed in the vast majority of human PDA [1]. Activating mutations in the Kras oncogene have been observed in PanIN lesions, suggesting that deregulation of Ras signaling is a key component during the transformation of epithelial cells [29], [30]. Support for this notion comes from studies in Pdx-Cre;KrasG12D transgenic mice in which expression of the prevalent KrasG12D mutation in pancreatic epithelial cells results in the formation of tumors that resemble human PDA [31]. To determine whether increased Wnt signaling is a common phenomenon during PDA formation in different species, we examined pancreata from Pdx-Cre;KrasG12D and Pdx-Cre;KrasG12D;p53f/+ mice by immunohistochemistry. In support of the human data, PanIN lesions in Pdx-Cre;KrasG12D and Pdx-Cre;KrasG12D;p53f/+ mice displayed changes in ss-catenin localization and increased expression of Tcf4, a mediator of canonical Wnt signaling (Fig. 1A-D and Table S1). Quantitative PCR for Wnt target genes showed a moderate increase in axin2 expression in Pdx-Cre;KrasG12D pancreata marked by PanIN lesions (Fig. S2). In order to determine whether accumulation of beta-catenin effectively correlated with Wnt signaling activity we generated Pdx-Cre;KrasG12D;TOPGal mice. Due to the expression of the LacZ-reporter gene under control of Wnt signaling responsive TCF-binding sites, the TOPGal mice provide an excellent means to identify cells within a given tissue that respond to canonical Wnt signaling [32]. While ss-galactosidase staining is absent in pancreata of control mice (wild type, TOPGal and Pdx-Cre;TOPGal animals were used as negative controls) (Fig. 1E and data not shown), pronounced ss-galactosidase activity is noted in epithelial cells of PanIN lesions of compound Pdx-Cre;KrasG12D;TOPGal mice (Fig. 1F). Thus, immunohistochemical staining, quantitative PCR for canonical Wnt target genes, and analysis of Wnt reporter mice indicate increased Wnt/ss-catenin signaling during the formation of PDA in human samples and mouse models of this disease.
###end p 13
###begin title 14
###xml 26 31 <span type="species:ncbi:10090">mouse</span>
Active Wnt signaling in a mouse model of PDA.
###end title 14
###begin p 15
###xml 211 215 205 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 219 222 213 216 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f/+</sup>
###xml 199 222 193 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx-Cre;Kras<sup>G12D</sup>;p53<sup>f/+</sup></italic>
###xml 711 715 696 700 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 699 715 684 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx-Cre;Kras<sup>G12D</sup></italic>
###xml 791 798 776 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Top-gal</italic>
###xml 819 823 804 808 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 807 831 792 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx-Cre;Kras<sup>G12D</sup>;Top-gal</italic>
###xml 872 879 857 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Top-gal</italic>
###xml 968 972 952 956 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 956 980 940 964 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx-Cre;Kras<sup>G12D</sup>;Top-gal</italic>
###xml 618 623 <span type="species:ncbi:10090">mouse</span>
###xml 836 840 <span type="species:ncbi:10090">mice</span>
A. Immunostaning for beta-Catenin in a control pancreas is confined to the plasma membrane. B. In contrast, cytoplasmic beta-catenin expression is observed in PanIN lesions and tumor of a 8-week old Pdx-Cre;KrasG12D;p53f/+ pancreas. The tumor is outlined in red. Note the accumulation of beta-catenin in the epithelial cells (brown staining). Two PanIN lesions are outlined in light blue. The black arrow points at cells that have retained membranous beta-catenin, while the red arrows point at areas of accumulation of beta-catenin in the cytoplasm. C. Tcf4 is expressed at a low level in ductal cells in a wild-type mouse pancreas. D. Elevated expression of Tcf4 in PanIN lesions of a 12-week old Pdx-Cre;KrasG12D pancreas. E, F. LacZ staining of pancreatic tissue of adult (6 months old) Top-gal (E) and Pdx-Cre;KrasG12D;Top-gal (F) mice. No staining is present in the Top-gal pancreas. ss-galactosidase activity is detected in the PanIN lesions of the Pdx-Cre;KrasG12D;Top-gal pancreas, indicating activation of the canonical Wnt pathway. The black bar represents 35 microm in A-D, 67.5 microm in E, F.
###end p 15
###begin title 16
###xml 45 50 <span type="species:ncbi:9606">human</span>
The canonical Wnt signaling arm is active in human pancreatic adenocarcinoma
###end title 16
###begin p 17
###xml 223 253 223 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WNT 11, WNT 7b, WNT 5b, WNT 2b</italic>
###xml 280 284 280 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5</italic>
###xml 289 293 289 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP6</italic>
###xml 321 325 321 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF3</italic>
###xml 330 334 330 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF4</italic>
###xml 410 417 410 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001155-g002">Fig. 2A</xref>
###xml 434 438 434 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF1</italic>
###xml 443 447 443 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LEF1</italic>
###xml 342 347 <span type="species:ncbi:9606">human</span>
To understand whether sustained Wnt signaling is important for cancer cell proliferation we included established pancreatic cancer cell lines in our analysis. First, we used RT-PCR to demonstrate expression of Wnt ligands (WNT 11, WNT 7b, WNT 5b, WNT 2b), Wnt ligand co-receptors LRP5 and LRP6, and transcription factors TCF3 and TCF4, in 26 human PDA cell lines derived from either primary or metastatic PDA (Fig. 2A). Expression of TCF1 and LEF1, transcriptional activators of the canonical Wnt signaling arm in other tissues, were expressed only in a subset of cell lines. These data suggest that the proteins necessary for active Wnt signaling are expressed at significant levels in all PDA cell lines analyzed.
###end p 17
###begin title 18
###xml 27 32 <span type="species:ncbi:9606">human</span>
Wnt signaling is active in human pancreatic adenocarcinoma cell lines.
###end title 18
###begin p 19
###xml 69 74 <span type="species:ncbi:9606">human</span>
A. RT-PCR analysis for components of the Wnt signaling pathway in 26 human pancreatic adenocarcinoma cell lines: 1-MiaPaca2; 2-Panc1; 3-CFPAC1; 4-HPAFII; 5-Capan-2; 6-AsPC1; 7-Hs766T; 8-BxPC3; 9-COLO357; 10-L3.3; 11-L3.6sl; 12-L3.6pl; 13-SW1990; 14-SU86.86; 15-PL45; 16-HPAC; 17-MPanc96; 18-Panc1.28; 19-Panc2.03; 20-Panc2.13; 21-Panc3.27; 22-Panc4.21; 23-Panc5.04; 24-Panc6.03; 25-Panc8.13; 26-Panc10.05. B. Wnt signaling is active in all nine pancreatic adenocarcinoma cell lines tested, as indicated by the activation of the Top-Flash reporter (black) compared to the basal activity of the Fop-Flash reporter (white). Renilla luciferase was used to normalize for transfection efficiency. Error bars are shown as St. Dev. P-values were calculated in comparison to control Fop-Flash activity (white bars). *, p<0.05; **, p<0.01.
###end p 19
###begin p 20
###xml 254 258 254 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-vandeWetering1">[33]</xref>
###xml 532 539 532 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001155-g002">Fig. 2B</xref>
To quantitatively evaluate the degree of Wnt signaling activity in a subset of these cell lines (n = 9) we measured luciferase expression controlled by concatemers of 'TCF optimal sites' (Top) upstream of a minimal thymidine kinase (TK) promoter element [33]. Concatemers of TCF 'far from optimal sites' (Fop) upstream of the TK-promoter served as control for Wnt independent, basal activity of the reporter construct. We detected activation of the Top-Flash reporter in each of the nine different adenocarcinoma cell lines tested (Fig. 2B). The majority of cell lines displayed a 3 to 5 fold relative activation of the Top-FLASH reporter. In comparison, relative Top-FLASH activity in the SW480 and HCT116 colon cancer cell lines was greater than that seen in any PDA cell lines (>6 Top/Fop ratio and >10 Top/Fop ratio respectively, data not shown), indicating that the majority of PDA cell lines show a moderate, but significant increase in Wnt activity.
###end p 20
###begin title 21
Inhibition of Wnt signaling reduces cell proliferation and increases apoptosis in pancreatic adenocarcinoma cells
###end title 21
###begin p 22
###xml 300 304 300 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Jaffee1">[34]</xref>
###xml 659 663 656 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Icat</italic>
###xml 663 667 660 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Tago1">[35]</xref>
###xml 699 704 696 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lef-1</italic>
###xml 706 714 703 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dn-Lef-1</italic>
###xml 793 800 790 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001155-g003">Fig. 3A</xref>
###xml 1051 1061 1047 1056 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#223;&#8211;CATENIN</italic>
###xml 1061 1065 1056 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Verma1">[36]</xref>
###xml 1231 1241 1225 1234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#223;-CATENIN</italic>
###xml 1249 1256 1242 1249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001155-g003">Fig. 3B</xref>
Four pancreatic adenocarcinoma cell lines were selected for in depth analysis of the requirement of Wnt signaling in PDA cells. Two well-established lines (CFPAC, BxPC3), a line with high metastatic potential (L3.6sl), and a line closely resembling a primary tumor phenotype (Panc4.21) were examined [34]. All four lines express significant levels of non-phosphorylated ss-CATENIN, another reliable marker of active Wnt/ss-CATENIN signaling (data not shown). The requirement of Wnt/ss-CATENIN signaling for PDA cell proliferation and survival was assessed by ectopically expressing known pathway inhibitors. Co-transfection with the endogenous Wnt inhibitor, Icat[35] or a dominant negative form of Lef-1 (dn-Lef-1), resulted in reduction of Top-Flash activity in the 4 PDA cell lines tested (Fig. 3A). In contrast, FOP-Flash activity was not affected by Icat or dn-Lef co-transfection (data not shown). Previous studies have shown effective reduction of Wnt/ss-CATENIN signaling in colon cancer cell lines upon treatment with siRNAs directed against ss-CATENIN[36]. Using a similar strategy, we observed a significant and dose dependant reduction in ss-CATENIN protein levels in pancreatic cancer cell lines transfected with anti-ss-CATENIN siRNA (Fig. 3B). Thus, Wnt/ss-CATENIN signaling in PDA cells can be blocked by treatment with three distinct and well-established pathway inhibitors.
###end p 22
###begin title 23
Inhibition of Wnt signaling blocks adenocarcinoma cell proliferation.
###end title 23
###begin p 24
###xml 270 274 270 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Icat</italic>
###xml 308 312 308 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lef1</italic>
###xml 314 319 314 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dnLef</italic>
###xml 375 379 375 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Icat</italic>
###xml 383 389 383 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dn-Lef</italic>
###xml 723 730 720 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CATENIN</italic>
###xml 830 837 824 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CATENIN</italic>
###xml 940 947 928 935 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CATENIN</italic>
###xml 1120 1134 1105 1119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Icat&#8211;IRES-eGFP</italic>
###xml 1154 1158 1139 1143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Icat</italic>
###xml 1194 1203 1179 1188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRES-eGFP</italic>
###xml 1205 1210 1190 1195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dnLef</italic>
###xml 1375 1384 1360 1369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRES-eGFP</italic>
###xml 1614 1621 1598 1605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CATENIN</italic>
###xml 1772 1779 1755 1762 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CATENIN</italic>
###xml 1823 1830 1805 1812 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CATENIN</italic>
###xml 2086 2090 2068 2072 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Icat</italic>
###xml 2120 2123 2102 2105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lef</italic>
###xml 2158 2165 2139 2146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CATENIN</italic>
A. Inhibition of Wnt signaling in four pancreatic adenocarcinoma cell lines. Cells transfected with Fop-Flash (white) or Top-Flash (light gray) reporter constructs were co-transfected with an empty expression vector or an expression vector containing the Wnt-inhibitors Icat (dark gray) or dominant-negative Lef1 (dnLef; black). Fop-Flash activity was not affected by either Icat or dn-Lef co-transfection, thus only one Fop-Flash data point is shown. The significant reduction of Top-Flash activity in cells expressing the inhibitors indicates inhibition of Wnt signaling in pancreatic cancer cells. P-values were calculated in comparison to Top-Flash activity (light gray bar). B. Immunofluorescent staining against beta-CATENIN in four pancreatic adenocarcinoma cell lines after transfection with a siRNA directed against beta-CATENIN. The beta-CATENIN protein levels are dramatically decreased in a dose-dependent manner following beta-CATENIN siRNA transfection. Control siRNA transfected cells have beta-CATENIN levels indistinguishable from those found in untransfected cells (untreated). C. Transfection with an Icat-IRES-eGFP expression vector (Icat, black) or dominant negative Lef - IRES-eGFP (dnLef, gray) strongly inhibits growth of four pancreatic cancer cells lines, measured as the ability to incorporate BrdU. Control cells (white) were transfected with the IRES-eGFP expression vector; all cells were harvested 48 hrs after transfection. P-values are shown in comparison to control transfected cells. D. Proliferation is reduced in a dose-dependent manner in cells treated for 48hrs with anti-ss-CATENIN siRNA (dark grey, black,) compared to control cells (white). Untreated (no siRNA), white columns; control siRNA (300 nM), light grey columns; anti-ss-CATENIN siRNA (100 nM), dark grey columns; anti-ss-CATENIN siRNA (300 nM), black columns. P-values are shown in comparison to untreated controls (white columns). E. Level of apoptosis, measured as cells with DNA content lower than the diploid amount, in control transfected cells (white) or cells transfected with Icat (black) or dominant negative Lef (grey). F. Treatment with anti-ss-CATENIN siRNA increases levels of apoptosis in a concentration-dependent manner. Error bars are shown as St. Dev.; P-values, #, not significant; *, p<0.05; **, p<0.01.
###end p 24
###begin p 25
###xml 304 308 303 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Icat</italic>
###xml 313 321 312 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dn-Lef-1</italic>
###xml 342 346 341 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRES</italic>
###xml 382 386 381 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eGFP</italic>
###xml 394 398 393 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Icat</italic>
###xml 404 412 403 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dn-Lef-1</italic>
###xml 611 615 610 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Icat</italic>
###xml 619 627 618 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dn-Lef-1</italic>
###xml 716 726 715 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001155-g003">Fig. 3C, E</xref>
###xml 819 829 817 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#223;-CATENIN</italic>
###xml 836 840 833 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Verma1">[36]</xref>
###xml 842 852 839 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001155-g003">Fig. 3D, F</xref>
###xml 857 866 854 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001155.s003">Figure S3</xref>
Wnt/ss-CATENIN signaling controls cell proliferation and survival in tissues other than pancreas. To test whether inhibition of Wnt signaling is sufficient to block cell proliferation in pancreatic adenocarcinoma cells, we measured BrdU incorporation in cells transiently transfected with Wnt inhibitors Icat and dn-Lef-1. The presence of an IRES sequence driving the expression of eGFP in the Icat- and dn-Lef-1-constructs allowed sorting and comparison of GFP/target gene negative control and GFP/target gene positive cells by flow cytometry. Transfection of the four pancreatic cancer cell lines with either Icat or dn-Lef-1 led to a significant decrease in cell proliferation and a marked increase in apoptosis (Fig. 3C, E). Similar results were obtained when ss-CATENIN function was specifically blocked with anti-ss-CATENIN siRNA [36] (Fig. 3D, F and Figure S3). Notably, we found that the reduction in cell proliferation and the increase in apoptosis upon ss-CATENIN knockdown was dose-dependent. The significant inhibition of cell proliferation and induction of apoptosis via inhibition of Wnt signaling through three different mechanisms strongly supports a role for Wnt signaling in PDA growth and survival.
###end p 25
###begin title 26
Hedgehog signaling regulates Wnt activity in untransformed duct cells.
###end title 26
###begin p 27
###xml 121 125 121 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI2</italic>
###xml 131 135 131 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI2</italic>
###xml 184 188 184 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI2</italic>
###xml 384 388 384 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lef1</italic>
###xml 394 400 394 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lef&#8211;da</italic>
###xml 444 450 444 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lef&#8211;da</italic>
###xml 677 681 677 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI2</italic>
###xml 950 954 950 954 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI2</italic>
###xml 1114 1121 1111 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CATENIN</italic>
###xml 1315 1321 1312 1318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI1/2</italic>
###xml 1463 1466 1457 1460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI</italic>
###xml 2257 2270 2242 2255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx-Cre;CLEG2</italic>
###xml 2371 2375 2353 2357 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 2353 2375 2335 2357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx-Cre;CLEG2;Kras<sup>G12D</sup></italic>
###xml 1763 1768 <span type="species:ncbi:9606">human</span>
###xml 2066 2071 <span type="species:ncbi:10090">mouse</span>
###xml 2271 2276 <span type="species:ncbi:10090">mouse</span>
A. Activity of the Wnt and Hedgehog pathways in control PDCs and stable clones transfected with dominant-active forms of GLI2 (PDC-GLI2). Activation of the Hedgehog pathway in two PDC-GLI2 clones (#1, #2) results in significant increase in Wnt signaling activity. B. Activity of the Wnt and Hedgehog pathways in control PDCs and PDCs stably transfected with a dominant active form of Lef1 (PDC-Lef-da). Activation of the Wnt pathway in the PDC-Lef-da cells does not affect the level of Hedgehog signaling. Error bars are shown as St. Dev. P-values, #, not significant; **p<0.01. C. PDC cells were stably transfected with a myc-tagged version of the constitutive active form of GLI2 (GLI2-myc fusion protein). Immunostaining using an anti-myc antibody confirms GLI2 expression in transfected cells. Untransfected PDC cells are shown as negative control. Immunostaining for Tcf4 is not detectable in wt PDC cells, but it is strongly upregulated in PDC-GLI2 cells. D. Immunohistochemistry analysis of Panc4.21 and L3.6sl pancreatic cancer cell lines shows that inhibition of the Wnt signaling pathway using anti-beta-CATENIN siRNA (100nM) results in a strong downregulation of TCF4 expression compared to control cells (transfected with an unrelated siRNA). Similarly, inhibition of the Hedgehog pathway using an anti-GLI1/2 siRNA (100 nM) results in TCF4 downregulation; the same effect is observed in cells treated with a combination of anti-beta-CATENIN and anti-GLI1/2 siRNA (each 100nM). E. Quantification of Tcf4 expression in PDC (white) and PDC-GLI2 (black) cells. At least 100 cell nuclei were scored for Tcf4 expression and the percentage of positive nuclei is shown in the histogram. F. Quantification of TCF4 positive nuclei following siRNA treatment in human PDA cell lines. At least 100 nuclei were scored for each category: control siRNA (white), anti-beta-CATENIN siRNA (light gray), anti-GLI siRNA (dark gray) and a combination of both siRNAs (black). Error bars are shown as St. Dev.; p-values #, not significant; *p<0.05; **, p<0.01. G. In wild-type mouse pancreas tissue, beta-catenin is only localized at the cell membrane. H. Presence of nuclear beta-catenin in a fraction of the tumors cells in an undifferentiated pancreatic tumor of a Pdx-Cre;CLEG2 mouse. I. Cytoplasmic and nuclear beta-catenin staining in the PanIN lesions of a Pdx-Cre;CLEG2;KrasG12D pancreas. The black bar represents 35 microm in G-I.
###end p 27
###begin p 28
###xml 218 222 217 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Icat</italic>
###xml 450 460 448 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#223;-CATENIN</italic>
###xml 591 599 588 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dn-Lef-1</italic>
###xml 674 684 670 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001155-g003">Fig. 3C, E</xref>
Previous reports have demonstrated an important role for ss-CATENIN in cell adhesion as part of a protein complex that includes E-cadherin. Therefore, disruption of this protein aggregate through ectopic expression of Icat or treatment with anti-ss-CATENIN siRNAs could affect cell viability by perturbing critical functions of E-cadherin rather than via decreased Wnt signaling. The E-CADHERIN expression pattern in the cell lines was unaffected by ss-CATENIN- siRNA knockdown (data not shown). In addition, a similar reduction in cell proliferation and increase in apoptosis was seen with dn-Lef-1 transfection, that specifically blocks ss-CATENIN mediated transcription (Fig. 3C, E). These results suggest that inhibition of Wnt/ss-CATENIN transcriptional activity, rather than alteration in ss-CATENIN/E-CADHERIN interaction, is critical for the observed effects on cell proliferation and apoptosis.
###end p 28
###begin title 29
Hedgehog signaling regulates Wnt signaling in untransformed pancreatic ductal epithelial cells and in pancreatic cancer cells
###end title 29
###begin p 30
###xml 74 78 73 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Murtaugh1">[11]</xref>
###xml 80 92 79 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001155-g001">Figure 1A, E</xref>
###xml 430 433 427 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Berman1">[6]</xref>
###xml 435 438 432 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Thayer1">[7]</xref>
###xml 512 516 509 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Pinson1">[37]</xref>
###xml 518 522 515 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Parr1">[38]</xref>
###xml 610 614 607 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Hruban2">[39]</xref>
###xml 729 733 726 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Schreiber1">[40]</xref>
###xml 975 979 972 976 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI2</italic>
###xml 979 983 976 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Roessler1">[41]</xref>
###xml 1013 1023 1010 1020 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smoothened</italic>
###xml 1025 1030 1022 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SmoA1</italic>
###xml 1099 1106 1096 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001155-g004">Fig. 4C</xref>
###xml 1330 1336 1327 1333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001155-g004">Fig 4A</xref>
###xml 1450 1456 1447 1453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001155-g004">Fig 4A</xref>
###xml 713 719 <span type="species:ncbi:10090">murine</span>
###xml 1633 1638 <span type="species:ncbi:9606">human</span>
Canonical Wnt/ss-catenin signaling is absent from normal mature pancreata [11] (Figure 1A, E). Our data and previously published reports show induction of ss-catenin signaling during PanIN formation, raising the question of the mechanism by which Wnt/ss-catenin signaling is induced. Hedgehog signaling, another embryonic signaling pathway, has previously been implicated in the initiation and growth of pancreatic adenocarcinoma [6], [7] as well as regulation of Wnt activity during mammalian organ development [37], [38]. Pancreatic ductal epithelial cells may constitute the putative cell of origin for PDA [39]. A previously described protocol allows the isolation of pancreatic duct cells (PDCs) from mature murine pancreas [40]. We used these cells to investigate the effect of Hedgehog signaling on Wnt activity in non-transformed epithelial cells. Ectopic activation of Hedgehog activity in PDCs was obtained either through expression of a dominant-active version of GLI2[41] or a dominant-active form of Smoothened (SmoA1). Expression of the transgenes was confirmed by immunofluorescence (Fig. 4C and data not shown). As expected, the activity of the Hedgehog pathway was significantly up-regulated in PDC-SmoA1 and PDC-GLI2 compared to PDCs, as measured by luciferase activity of a Hedgehog reporter construct, Gli-BS (Fig 4A and data not shown). Interestingly, the activity of the Wnt reporter TOP-Flash was also significantly increased (Fig 4A), thus showing that activation of Hedgehog signaling upregulates Wnt activity in pancreatic duct cells. These findings support the notion that the induction of Wnt activity in human PDA can occur in the absence of signature mutation in APC or ss-CATENIN that are commonly found in other cancers.
###end p 30
###begin p 31
###xml 144 148 144 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lef1</italic>
###xml 151 158 151 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lef1-da</italic>
###xml 175 184 175 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRES-eGFP</italic>
###xml 431 439 431 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;Lef1&#8211;da</italic>
###xml 588 595 588 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001155-g004">Fig. 4B</xref>
To test whether Wnt signaling regulates Hedgehog activity, PDCs were transfected with an expression vector coding for a dominant-active form of Lef1, (Lef1-da) followed by an IRES-eGFP sequence. Target gene expression in pools of transfected cells was verified by Western blot and by flow cytometry using eGFP as a marker (data not shown). Top-Flash reporter assays confirmed an approximately 4-fold increase in Wnt activity in PDC-Lef1-da cells compared to PDCs. However, ectopic activation of Wnt signaling did not induce luciferase activity of the Hedgehog responsive Gli-BS reporter (Fig. 4B).
###end p 31
###begin title 32
Hedgehog signaling regulates expression of TCF4 in pancreatic duct and cancer cells
###end title 32
###begin p 33
###xml 661 665 651 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Hecht1">[42]</xref>
###xml 736 740 726 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Ishitani1">[43]</xref>
###xml 742 746 732 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF4</italic>
###xml 834 841 824 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001155-g002">Fig. 2A</xref>
###xml 1038 1048 1028 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001155-g004">Fig. 4C, E</xref>
###xml 1205 1215 1195 1204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#223;-CATENIN</italic>
###xml 1227 1236 1216 1225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI1/GLI2</italic>
###xml 1345 1355 1334 1344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001155-g004">Fig. 4D, F</xref>
###xml 1577 1584 1566 1573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001155.s004">Fig. S4</xref>
While a number of studies have demonstrated that Hedgehog and Wnt pathways regulate each other's activity, the molecular mechanisms underlying this regulation remain unresolved. Activation of the canonical Wnt pathway requires the physical interaction of nuclear ss-CATENIN and TCF/LEF transcription factors. beta-CATENIN and factors of the TCF/LEF family of DNA-binding molecules are the downstream effectors of the Wnt signaling cascade. TCF4 is expressed in the gastrointestinal tract and in tumors of gastrointestinal origin. Formation of the beta-CATENIN/TCF4 complex is regulated at different levels, such as accumulation and localization of beta-CATENIN [42], interaction between the two factors, and ability of TCF4 to bind DNA [43]. TCF4 mRNA is expressed at high levels in all pancreatic adenocarcinoma cell lines analyzed (Fig. 2A). Little Tcf4 protein was detected in a small proportion of pancreatic duct cells, however, GLI2-mediated activation of Hedgehog signaling induced robust Tcf4 expression in pancreatic duct cells (Fig. 4C, E). To test whether Hedgehog signaling controls TCF4 expression in pancreatic cancer cells, we treated Panc4.21 and L3.6sl cells with siRNAs directed against ss-CATENIN as well as GLI1/GLI2. Interestingly, inhibition of either Hedgehog or Wnt signaling resulted in loss of nuclear TCF4 expression (Fig. 4D, F). In addition, treatment of the pancreatic cancer cells with the Hedgehog inhibitor cyclopamine resulted in a significant down-regulation of TCF4 protein and Top-Flash activity in the CFPAC, Panc4.21 and L3.6 cell lines (Fig. S4). The observation that TCF4 levels and Top-Flash activity were not affected in the cyclopamine insensitive cell line BxPC3 cells further support the notion that TCF4 expression is regulated in response to Hedgehog signaling. Thus, Hedgehog signaling regulates the Wnt pathway at least in part by affecting the concentration of nuclear TCF4 in pancreatic cancer cells.
###end p 33
###begin p 34
###xml 85 92 84 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 209 222 208 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx-Cre;CLEG2</italic>
###xml 301 314 300 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx-Cre;CLEG2</italic>
###xml 372 376 371 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-PascadiMagliano2">[44]</xref>
###xml 494 501 492 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001155-g004">Fig. 4H</xref>
###xml 816 820 812 816 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 798 820 794 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx-Cre;CLEG2;Kras<sup>G12D</sup></italic>
###xml 822 829 818 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001155-g004">Fig. 4I</xref>
###xml 106 121 <span type="species:ncbi:10090">transgenic mice</span>
###xml 315 319 <span type="species:ncbi:10090">mice</span>
###xml 734 738 <span type="species:ncbi:10090">mice</span>
###xml 857 862 <span type="species:ncbi:9606">human</span>
###xml 875 880 <span type="species:ncbi:10090">mouse</span>
To test whether Hedgehog activation is sufficient to induce Wnt/ss-catenin signaling in vivo, we analyzed transgenic mice marked by ectopic expression of an activated version of GLI2 in pancreatic epithelium (Pdx-Cre;CLEG2). We have previously reported that forced activation of Hedgehog signaling in Pdx-Cre;CLEG2 mice results in the formation of undifferentiated tumors [44]. Immunohistochemical analysis revealed that tumor cells are marked by cytoplasmic and nuclear ss-catenin expression (Fig. 4H). Thus, epithelial-specific activation of Hedgehog signaling is sufficient to induce Wnt/ss-catenin signaling in pancreatic cells. Furthermore, nuclear ss-catenin is observed in PanIN as well as undifferentiated tumors that form in mice in which both Kras and Hedgehog signaling are deregulated (Pdx-Cre;CLEG2;KrasG12D, Fig. 4I). Summarily, our data from human, transgenic mouse and cell culture experiments suggest that Wnt/ss-catenin signaling is commonly activated in preneoplastic lesions and PDA and that the activation of the pathway is regulated at least in part by increased Hh signaling.
###end p 34
###begin p 35
###xml 423 427 423 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-vandenBrink1">[45]</xref>
###xml 429 433 429 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Qualtrough1">[46]</xref>
###xml 531 535 531 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Taipale1">[47]</xref>
###xml 874 878 874 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-FrankKamenetsky1">[48]</xref>
###xml 880 884 880 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Lepourcelet1">[49]</xref>
Notably, both Hedgehog and Wnt signaling appear to be important for the survival of pancreatic adenocarcinoma cells. This raises the question whether the cooperation between these pathways is restricted to the pancreas or whether similar mechanisms can also be found in other tumors. With the exception of the colon where conflicting results regarding the relationship between Hedgehog and Wnt signaling have been reported [45], [46], activation rather than inhibition of both pathways is typically correlated with tumor formation [47]. Hedgehog and Wnt activity have been noted in a number of different tumors and future studies will analyze whether combined antagonist treatments could present novel therapeutic options for these tumors. This is of particular importance as novel, more efficient and more specific inhibitors of both pathways are currently being developed [48], [49].
###end p 35
###begin title 36
Materials and Methods
###end title 36
###begin title 37
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse strains
###end title 37
###begin p 38
###xml 8 13 8 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">early</sup>
###xml 0 13 0 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre<sup>early</sup></italic>
###xml 20 24 20 24 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Heiser1">[10]</xref>
###xml 26 30 26 30 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Gu1">[50]</xref>
###xml 55 60 55 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CLEG2</italic>
###xml 67 102 67 102 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A. Ermilov et al., in preparation ;</bold>
###xml 102 106 102 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-PascadiMagliano2">[44]</xref>
###xml 125 129 125 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 117 129 117 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL-Kras<sup>G12D</sup></italic>
###xml 181 185 181 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 208 212 208 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Hingorani1">[31]</xref>
###xml 266 271 266 271 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">early</sup>
###xml 276 280 276 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 290 295 290 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">early</sup>
###xml 259 301 259 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx-Cre<sup>early</sup>;Kras<sup>G12D</sup> , Pdx-Cre<sup>early</sup>;CLEG2</italic>
###xml 313 318 313 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">early</sup>
###xml 329 333 329 333 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 306 333 306 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx-Cre<sup>early</sup>;CLEG2;Kras<sup>G12D</sup></italic>
###xml 342 347 342 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">early</sup>
###xml 352 356 352 356 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 335 356 335 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx-Cre<sup>early</sup>;Kras<sup>G12D</sup></italic>
###xml 384 391 384 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Top-gal</italic>
###xml 411 415 411 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-DasGupta1">[32]</xref>
###xml 14 18 <span type="species:ncbi:10090">mice</span>
###xml 61 65 <span type="species:ncbi:10090">mice</span>
###xml 130 134 <span type="species:ncbi:10090">mice</span>
###xml 357 361 <span type="species:ncbi:10090">mice</span>
###xml 405 409 <span type="species:ncbi:10090">mice</span>
Pdx1-Creearly mice ([10], [50]) were intercrossed with CLEG2 mice (A. Ermilov et al., in preparation ;[44]) and with LSL-KrasG12D mice (a gift from David Tuveson referred to as KrasG12D throughout the text) ([31]) to generate either double or triple mutants: Pdx-Creearly;KrasG12D , Pdx-Creearly;CLEG2 and Pdx-Creearly;CLEG2;KrasG12D. Pdx-Creearly;KrasG12D mice were crossed with the Top-gal Wnt reporter mice ([32]). All studies were conducted in compliance with University of California IACUC guidelines.
###end p 38
###begin title 39
Immunohistochemistry and Immunofluorescence
###end title 39
###begin p 40
###xml 71 75 71 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-PascadiMagliano2">[44]</xref>
###xml 740 755 739 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Axioscop 2 plus</italic>
###xml 121 126 <span type="species:ncbi:10090">mouse</span>
###xml 187 192 <span type="species:ncbi:10090">mouse</span>
###xml 301 306 <span type="species:ncbi:10090">mouse</span>
###xml 537 542 <span type="species:ncbi:10090">mouse</span>
Histological analysis of tissues was performed as described previously [44]. The following primary antibodies were used: mouse anti-ss-catenin (1:200 dilution, Becton and Dickinson, NJ), mouse anti-Tcf4 (clone 6H5-3, 1:100 dilution, Upstate, NY). For immunohistochemistry, we used a biotinylated anti-mouse antibody (Jackson immunoresearch, PA) at a 1:300 dilution. 3-3'-Diaminobenzidine tetrahydrochloride was used as a chromogen. Bright-field images were acquired using a Zeiss Axio Imager D1 scope. Alternatively, we used a FITC anti-mouse secondary antibody (Jackson immunoresearch, PA), and the slides were mounted using Vectashlield mounting medium vith DAPI (Vector laboratories, CA). Immunofluorescent images were acquired using an Axioscop 2 plus microscope (Zeiss, Germany).
###end p 40
###begin title 41
X-gal Staining
###end title 41
###begin p 42
###xml 212 213 206 207 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were perfused with ice-cold fixative [0.25% glutaraldehyde in phosphate-buffered saline (PBS)]. Pancreas samples were fixed for 90 minutes at 4degreesC. Tissues were then washed with PBS containing 2 mM MgCl2 for 1 hour and stained with LacZ solution (1 mg/ml X-gal, 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide, 2 mM MgCl2, 0.02%(v/v) NP40, and 0.01%(w/v) sodium-deoxycholate in PBS) at room temperature for 24 hours. After staining, tissues were post-fixed with buffered formalin, embedded in paraffin, sectioned, and counterstained with nuclear fast red.
###end p 42
###begin title 43
Cell culture and transfection
###end title 43
###begin p 44
###xml 70 73 70 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Thayer1">[7]</xref>
###xml 130 134 130 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Schreiber1">[40]</xref>
###xml 134 138 134 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Deramaudt1">[51]</xref>
Tumor cell lines and cell culture protocols were previously described [7]. PDC cells growth conditions were previously published ([40][51]). Cells were transfected using Effectene reagent (QIAGEN, Germany) according to the manufacturer's instructions. For transient transfections, the cells were harvested 24 to 48 hrs after transfection, and the luciferase and renilla acivity were assayed using the dual luciferase kit (Promega, WI). Stable transfectant cells were generated by selecting with G418 at a concentration of 300 microg/ml. Single clones were isolated and amplified.
###end p 44
###begin title 45
RT-PCR
###end title 45
###begin p 46
###xml 338 348 334 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001155.s001">Methods S1</xref>
RNA from pancreatic cancer cells and PDCs was prepared using TRIzol reagent (Invitrogen, CA). 2 microg of total RNA were treated with DNAse RQ1 (Promega) prior to cDNA synthesis (using random hexamers and Superscript II reverse transcriptase, (Invitrogen, CA). The oligonucleotide sequences are described in the supplemental information (Methods S1).
###end p 46
###begin title 47
Anti-sense RNAs
###end title 47
###begin p 48
###xml 75 79 72 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Verma1">[36]</xref>
###xml 79 83 76 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001155-Sanchez1">[52]</xref>
Anti-beta-catenin and anti-GLI1 siRNA sequences were previously described ([36][52]). The Gli2 anti-sense siRNA sequence was: 5'-ACACCAACCAGAACAAGCAdTdT-3'. The siRNAs were synthesized by Dharmacon, Inc. (CO). The siRNAs were transfected using oligofectamine reagent (Invitrogen, CA) according to the manifacturer's instructions.
###end p 48
###begin title 49
BrdU incorporation assay
###end title 49
###begin p 50
BrdU incorporation assays were performing using the BD Biosciences BrdU flow kit according to the manufacturer's instructions.
###end p 50
###begin p 51
###xml 35 45 35 45 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001155.s001">Methods S1</xref>
Additional methods are provided in Methods S1.
###end p 51
###begin title 52
Supporting Information
###end title 52
###begin p 53
###xml 34 39 <span type="species:ncbi:9606">human</span>
###xml 81 86 <span type="species:ncbi:9606">human</span>
###xml 202 207 <span type="species:ncbi:9606">human</span>
Immunostaining of beta-CATENIN in human normal and cancer tissues. A. In control human pancreas beta-CATENIN is localized at the cell membrane in both acinar and duct cells. B, C, D. In three different human PDA samples beta-CATENIN is localized predominantly in the cytoplasm (D) and nucleus (B,C).
###end p 53
###begin p 54
(9.42 MB TIF)
###end p 54
###begin p 55
Click here for additional data file.
###end p 55
###begin p 56
###xml 171 175 <span type="species:ncbi:10090">mice</span>
###xml 181 185 <span type="species:ncbi:10090">mice</span>
Quantitative PCR for Wnt target genes (axin2, Lef1, Mmp-7, cyclinD1, Dkk2 and Dkk3) in pancreatic samples isolated from three wild type control and three Pdx-Cre;KrasG12D mice. All mice analyzed were 6 months old. Data are presented compared to expression of the household gene GUS.
###end p 56
###begin p 57
(0.36 MB TIF)
###end p 57
###begin p 58
Click here for additional data file.
###end p 58
###begin p 59
Inhibition of Wnt signaling induces apoptosis in pancreatic cancer cell lines. A. Relative apoptosis is measured by FACS using an anti-cleaved caspase 3 antibody in cells transfected with a control siRNA (control, white bars) or beta-catenin siRNA (black bars). B. Immunostaining for cleaved caspase 3 in cells transfected with a control siRNA or beta-catenin siRNA.
###end p 59
###begin p 60
(1.78 MB TIF)
###end p 60
###begin p 61
Click here for additional data file.
###end p 61
###begin p 62
The Hedgehog signaling pathway acts upstream of the Wnt signaling pathway in pancreatic cancer cells. A. Activity of the Top-Flash vector in pancreatic adenocarcinoma cells (black bars) is inhibited in response to cyclopamine (gray bars), an inhibitor of the Hedgehog signaling pathway. The first P-values indicate statistical significance in Top-Flash activation (black bars) in comparison to Fop-Flash activity (white bars). The second P-values show significance of reduction in Top-Flash activity upon cyclopamine treatment (gray vs black bars). B. Immunostaining of pancreatic cancer cells grown in control conditions or treated with cyclopamine for 24 hrs. With the exception of BxPC# cells, cyclopamine treatment strongly inhibits TCF4 expression in the cell lines analyzed. Green: anti-TCF4 antibody; blue: DAPI. C. Quantification of the percentage of TCF4 positive nuclei in control cells (white bars) and in cyclopamine-treated cells (black bars). P-values are shown in comparison to the control cells. Error bars are shown as St. Dev.; p-values #, not significant; *p<0.05; **, p<0.01.
###end p 62
###begin p 63
(1.71 MB TIF)
###end p 63
###begin p 64
Click here for additional data file.
###end p 64
###begin p 65
Upregulation of Wnt receptors, Wnt ligands and beta-CATENIN itself as well as downregulation of some inhibitors of Wnt signaling (IDAX and ICAT), together with genes whose transcription is mediated by beta-CATENIN, suggests activation of Wnt signaling in PDA.
###end p 65
###begin p 66
(0.18 MB DOC)
###end p 66
###begin p 67
Click here for additional data file.
###end p 67
###begin p 68
(0.05 MB DOC)
###end p 68
###begin p 69
Click here for additional data file.
###end p 69
###begin p 70
###xml 235 240 <span type="species:ncbi:10090">mouse</span>
###xml 344 349 <span type="species:ncbi:9606">human</span>
We would like to thank the members of the Hebrok lab, in particular John P. Morris IV, for critical reading of the manuscript. We would like to thank Max Muenke, NIGMS, for sharing the plasmid GLI2deltaN plasmid. The studies involving mouse models and pancreatic cancer cell lines were performed in Matthias Hebrok's lab. The studies involving human samples were performed in Andrew Biankin's lab.
###end p 70
###begin title 71
References
###end title 71
###begin article-title 72
Genetics and biology of pancreatic ductal adenocarcinoma.
###end article-title 72
###begin article-title 73
An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms.
###end article-title 73
###begin article-title 74
Molecular pathogenesis of precursor lesions of pancreatic ductal adenocarcinoma.
###end article-title 74
###begin article-title 75
Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia.
###end article-title 75
###begin article-title 76
Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis.
###end article-title 76
###begin article-title 77
Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours.
###end article-title 77
###begin article-title 78
Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis.
###end article-title 78
###begin article-title 79
Hedgehog signaling in cancer formation and maintenance.
###end article-title 79
###begin article-title 80
Hedgehog signaling in pancreas development.
###end article-title 80
###begin article-title 81
Stabilization of beta-catenin impacts pancreas growth.
###end article-title 81
###begin article-title 82
{beta}-Catenin is essential for pancreatic acinar but not islet development.
###end article-title 82
###begin article-title 83
Pancreas-Specific Deletion of beta-Catenin Reveals Wnt-Dependent and Wnt-Independent Functions during Development.
###end article-title 83
###begin article-title 84
Attenuated wnt signaling perturbs pancreatic growth but not pancreatic function.
###end article-title 84
###begin article-title 85
Sonic hedgehog directs specialised mesoderm differentiation in the intestine and pancreas.
###end article-title 85
###begin article-title 86
Hedgehog signaling regulates expansion of pancreatic epithelial cells.
###end article-title 86
###begin article-title 87
###xml 68 83 <span type="species:ncbi:10090">transgenic mice</span>
Expression patterns of Wnts, Frizzleds, sFRPs, and misexpression in transgenic mice suggesting a role for Wnts in pancreas and foregut pattern formation.
###end article-title 87
###begin article-title 88
Wnts and Hedgehogs: lipid-modified proteins and similarities in signaling mechanisms at the cell surface.
###end article-title 88
###begin article-title 89
Wnt signaling in the intestinal epithelium: from endoderm to cancer.
###end article-title 89
###begin article-title 90
The Wnt signaling pathway and its role in tumor development.
###end article-title 90
###begin article-title 91
###xml 66 71 <span type="species:ncbi:9606">human</span>
An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells.
###end article-title 91
###begin article-title 92
Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations.
###end article-title 92
###begin article-title 93
Subcellular distribution of Wnt pathway proteins in normal and neoplastic colon.
###end article-title 93
###begin article-title 94
Epithelial-cadherin and beta-catenin expression changes in pancreatic intraepithelial neoplasia.
###end article-title 94
###begin article-title 95
Dysregulation of beta-catenin expression correlates with tumor differentiation in pancreatic duct adenocarcinoma.
###end article-title 95
###begin article-title 96
###xml 114 119 <span type="species:ncbi:9606">human</span>
Extracellular sulfatases, elements of the wnt signaling pathway, positively regulate growth and tumorigenicity of human pancreatic cancer cells.
###end article-title 96
###begin article-title 97
Wnt/beta-catenin signaling is required for development of the exocrine pancreas.
###end article-title 97
###begin article-title 98
Wnt signaling regulates pancreatic ss-cell proliferation.
###end article-title 98
###begin article-title 99
Aberrant Wnt/ss-Catenin Signaling in Pancreatic Adenocarcinoma.
###end article-title 99
###begin article-title 100
K-ras mutations in pancreatic ductal proliferative lesions.
###end article-title 100
###begin article-title 101
Tumor-suppressive pathways in pancreatic carcinoma.
###end article-title 101
###begin article-title 102
###xml 81 86 <span type="species:ncbi:10090">mouse</span>
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse.
###end article-title 102
###begin article-title 103
Multiple roles for activated LEF/TCF transcription complexes during hair follicle development and differentiation.
###end article-title 103
###begin article-title 104
###xml 65 75 <span type="species:ncbi:7227">Drosophila</span>
Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF.
###end article-title 104
###begin article-title 105
Development and characterization of a cytokine-secreting pancreatic adenocarcinoma vaccine from primary tumors for use in clinical trials.
###end article-title 105
###begin article-title 106
Inhibition of Wnt signaling by ICAT, a novel beta-catenin-interacting protein.
###end article-title 106
###begin article-title 107
Small interfering RNAs directed against beta-catenin inhibit the in vitro and in vivo growth of colon cancer cells.
###end article-title 107
###begin article-title 108
###xml 59 63 <span type="species:ncbi:10090">mice</span>
An LDL-receptor-related protein mediates Wnt signalling in mice.
###end article-title 108
###begin article-title 109
###xml 78 83 <span type="species:ncbi:10090">mouse</span>
Dorsalizing signal Wnt-7a required for normal polarity of D-V and A-P axes of mouse limb.
###end article-title 109
###begin article-title 110
Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions.
###end article-title 110
###begin article-title 111
###xml 42 47 <span type="species:ncbi:10090">mouse</span>
Successful growth and characterization of mouse pancreatic ductal cells: functional properties of the Ki-RAS(G12V) oncogene.
###end article-title 111
###begin article-title 112
###xml 119 124 <span type="species:ncbi:9606">human</span>
A previously unidentified amino terminal domain regulates transcriptional activity of wild-type and disease-associated human GLI2.
###end article-title 112
###begin article-title 113
Curbing the nuclear activities of beta-catenin. Control over Wnt target gene expression.
###end article-title 113
###begin article-title 114
Regulation of lymphoid enhancer factor 1/T-cell factor by mitogen-activated protein kinase-related Nemo-like kinase-dependent phosphorylation in Wnt/beta-catenin signaling.
###end article-title 114
###begin article-title 115
Hedgehog/Ras interactions regulate early stages of pancreatic cancer.
###end article-title 115
###begin article-title 116
Indian Hedgehog is an antagonist of Wnt signaling in colonic epithelial cell differentiation.
###end article-title 116
###begin article-title 117
Hedgehog signalling in colorectal tumour cells: induction of apoptosis with cyclopamine treatment.
###end article-title 117
###begin article-title 118
The Hedgehog and Wnt signalling pathways in cancer.
###end article-title 118
###begin article-title 119
Small-molecule modulators of Hedgehog signaling: identification and characterization of Smoothened agonists and antagonists.
###end article-title 119
###begin article-title 120
Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex.
###end article-title 120
###begin article-title 121
Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors.
###end article-title 121
###begin article-title 122
N-cadherin and keratinocyte growth factor receptor mediate the functional interplay between Ki-RASG12V and p53V143A in promoting pancreatic cell migration, invasion, and tissue architecture disruption.
###end article-title 122
###begin article-title 123
Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling.
###end article-title 123
###begin p 124
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 124
###begin p 125
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: MP is supported by a grant from the National Pancreas Foundation. DAC was supported by a postdoctoral fellowship from the Ministerio de Educacion, Cultura y Deporte, of the Spanish Government and a postdoctoral fellowship from the Juvenile Diabetes Research Foundation. Research in AKR's laboratory is supported by grants from the National Pancreas Foundation and the NIH (DK60694). Research in AVB's laboratory is supported by the National Health and Medical Research Council of Australia, the St. Vincent's Clinic Foundation, the Cancer Institute NSW, the Royal Australasian College of Surgeons and the R.T. Hall Trust. AVB and SMH are supported by Cancer Institute NSW Fellowships. Research in MH's laboratory was supported by grants from the UCSF Comprehensive Cancer Center, a Lustgarten Foundation grant, and an NIH grant (CA112537-01).
###end p 125

